These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7667773)

  • 1. [The efficacy of intravenous enalapril administration in the combined therapy of a patient with congestive heart failure].
    Chel'tsov VV; Lepakhin VK; Maksimova VI; Fominova GP; Petukhov EM
    Ter Arkh; 1995; 67(6):25-6. PubMed ID: 7667773
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney insufficiency following use of enalapril for congestive heart failure].
    Botman CJ; Mulder AW; Hoorntje SJ
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1402-4. PubMed ID: 2821411
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA; Berezin AE
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Paul SD; Kuntz KM; Eagle KA; Weinstein MC
    Arch Intern Med; 1994 May; 154(10):1143-9. PubMed ID: 8185426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
    Tomiyama H; Watanabe G; Yoshida H; Doba N; Yamashina A
    Am Heart J; 2003 Jan; 145(1):E2. PubMed ID: 12514674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication nonadherence: Part II--A pilot study in patients with congestive heart failure.
    Rodgers PT; Ruffin DM
    Manag Care Interface; 1998 Sep; 11(9):67-9, 75. PubMed ID: 10187590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
    Dessì-Fulgheri P; Paci MV; Rappelli A
    Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of echocardiographic changes and the tactic of optimal therapy in patients with atrial fibrillation with chronical heart failure].
    Abuladze GV; Dzhindzholiia NA; Dzhashi IA; Narsiia EV; Gudzhedzhiani LA
    Georgian Med News; 2007 Apr; (145):42-5. PubMed ID: 17525498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dopamine in the combined treatment of heart failure in a patient with Abramov-Fiedler myocarditis].
    Sirenko IuN
    Vrach Delo; 1989 Apr; (4):41-3. PubMed ID: 2756682
    [No Abstract]   [Full Text] [Related]  

  • 11. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril.
    Terrovitis JV; Anastasiou-Nana MI; Alexopoulos GP; Tsolakis EJ; Margari ZJ; Drakos SG; Tsagalou EP; Papazoglou P; Efentakis S; Nanas JN
    J Heart Lung Transplant; 2006 Mar; 25(3):333-8. PubMed ID: 16507428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
    Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
    Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
    Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous molsidomine administration in heart failure. Part II: Comparison with nitroglycerin and effectiveness in nitrate tolerance].
    Störk T; Möckel M; Danne O; Müller R; Eichstädt H; Hochrein H
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():50-3. PubMed ID: 7968904
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute decompensated heart failure.
    Nemeth J
    CMAJ; 2007 Jul; 177(2):175; author reply 175-6. PubMed ID: 17638958
    [No Abstract]   [Full Text] [Related]  

  • 17. Dobutamine infusion for the treatment of congestive heart failure in the home care setting.
    Coffin MR
    J Intraven Nurs; 1994; 17(3):145-50. PubMed ID: 8064499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute congestive heart failure in the emergency department.
    Rogers RL; Feller ED; Gottlieb SS
    Cardiol Clin; 2006 Feb; 24(1):115-23, vii. PubMed ID: 16326261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neoton (exogenic phosphocreatinine) in combined therapy of chronic cardiac failure].
    Nedoshivin AO; Perepech NB
    Klin Med (Mosk); 1996; 74(9):45-8. PubMed ID: 9121090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.